Navellier & Associates Inc West Pharmaceutical Services Inc Transaction History

Navellier & Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$280.61 - $420.45 $11.6 Million - $17.3 Million	-41,237 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$357.49 - $445.92 $585,926 - $730,862	-1,639 Reduced 3.82%	41,237 $16.9 Million
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $84,070 - $98,510	209 Added 0.49%	42,876 $20.1 Million
Q3 2021 Oct 28, 2021	BUY	$363.01 - $468.47 $7.25 Million - $9.36 Million	19,972 Added 88.0%	42,667 $18.1 Million
Q2 2021 Aug 09, 2021	BUY	$284.77 - $363.2 $501,479 - $639,595	1,761 Added 8.41%	22,695 $8.15 Million
Q1 2021 May 12, 2021	BUY	$257.29 - $307.53 $686,192 - $820,182	2,667 Added 14.6%	20,934 $5.9 Million
Q4 2020 Feb 05, 2021	BUY	$261.16 - $301.66 $533,811 - $616,593	2,044 Added 12.6%	18,267 $5.18 Million
Q3 2020 Nov 09, 2020	BUY	$224.99 - $288.02 $3.65 Million - $4.67 Million	16,223 New	16,223 $4.46 Million

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.